See your doctor for a CONTOUR®NEXT Portfolio Blood Glucose Meter and test strips prescription.
Choose the CONTOUR®NEXT Portfolio Blood Glucose Meter that works best for you.
Remember, CONTOUR®NEXT Test Strips are always covered under Medicare Part B!*
Have your CONTOUR®NEXT Portfolio prescription filled at your pharmacy.
Test strips are covered when medically necessary and prescribed by your physician. Medicare will reimburse either 80% of the Medicare Fee Schedule or the actual charges, whichever is less.
More questions about Medicare?
Learn more about Medicare plans and coverage at: https://www.medicare.gov/pubs/pdf/11022-Medicare-Diabetes-Coverage.pdf.
CONTOUR® NEXT Test Strips
For non-insulin treated patients
For insulin treated patients
A doctor's prescription is required for Medicare reimbursement. If your doctor recommends that you test more often than Medicare's guidelines permit, your doctor may assist you in getting authorization from Medicare to receive more self-testing supplies which Medicare will cover after additional requirements are met. For more information, check with your doctor or see MLN Matters SE1008 for more info and use this link: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE1008.pdf
If you have any difficulty in obtaining your CONTOUR® NEXT test strips please call us (1-800-348-8100)
and we will help you find a Medicare supplier who will provide you with CONTOUR® NEXT test strips.
To find a supplier that’s enrolled in Medicare, visit www.medicare.gov/supplier or call
†10% applies to glucose levels ≥100 mg/dL. In multiple clinical trials examined by Bernstein et al., the CONTOUR®NEXT meter portfolio delivered at least 95% of results within 10% of the laboratory reference value for blood glucose concentrations ≥100 mg/dL and within ±10 mg/dL of the laboratory reference value for blood glucose concentrations <100 mg/dL.
‡ ±8.4% applies to values ≥100mg/dL. An ad hoc analysis demonstrated 95% of results fell within ±8.4 mg/dL or ±8.4% of the laboratory reference values for glucose concentrations <100 mg/dL or ≥100 mg/dL, respectively, when tested via subject-obtained capillary fingertip results (patients with diabetes).
*Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible and patient eligibility requirements. Visit www.medicare.gov for more information.
References: 1. Bernstein, R. et al. A new test strip technology platform for self-monitoring of blood glucose. Journal of Diabetes Science and Technology. 2013; 7(5):1386-1399. 2. Christiansen, M. et al. A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology. 2017, Vol. 11(3) 567-573.3. Ascensia Diabetes Care. Data on File. Market Research, Hall & Partners, conducted online April/May 2015